UDL-200 Tramadol

UDL-200 Tramadol is a long-acting analgesic tablet containing 200mg of tramadol hydrochloride in an extended-release matrix. This formulation is indicated for the management of chronic pain conditions requiring consistent, 24-hour pharmacological coverage. The tablet releases tramadol gradually, maintaining therapeutic plasma levels throughout the day and reducing the need for frequent dosing. The dual mechanism of action – combining weak opioid agonism with monoamine reuptake inhibition – provides effective relief for pain types that may not respond adequately to pure opioids alone. UDL-200 tablets must be administered whole and should not be crushed, divided, or chewed. This product is intended for patients with established opioid tolerance and should be used under proper medical supervision.